GLP-1 Isn’t a Miracle. Misusing It Is the Real Risk.

Written by Rishi Bhojnagarwala

Medically Reviewed by Dr. Hetal Pal, PhD in Nutrition Science

Over the past few months, GLP-1 medications like Ozempic, Wegovy, and Mounjaro have gone from being clinical tools to mass-market headlines.

What’s more interesting is who is now advertising them.

Many of the same companies that were, until recently, selling lifestyle programs, diet plans, supplements, and “sustainable weight loss” courses have suddenly changed their narrative.
Lifestyle doesn’t work, they now say. Biology must be fixed. GLP-1 is the answer.

This sudden shift deserves a closer look.

What GLP-1 Actually Does (And What It Doesn’t)

GLP-1 medications such as Mounjaro and Ozempic don’t “melt fat.”
They don’t magically fix metabolism.

What they do — very effectively — is reduce appetite and food cravings.

That’s it.

And that’s powerful.

For someone who is already motivated, already trying, and already understands what weight loss requires, GLP-1 simply removes the biggest friction point: constant hunger.

In other words, GLP-1 fast-tracks something people have always attempted on their own — a calorie deficit — but struggled to sustain.

The Inconvenient Truth No One Is Talking About

GLP-1 is not a one-time solution.

For most users, it becomes:

• A long-term medication
  
  

• A recurring monthly expense (₹5,000–₹10,000+ in India)
  
  

• A dependency that must be managed carefully
  
  

What many ads don’t disclose clearly is that stopping GLP-1 abruptly without the right lifestyle foundation often leads to regain.

This doesn’t make GLP-1 bad.
It makes how it’s used extremely important.

Can GLP-1 Be Used Short-Term?

Yes — but only if used correctly.

A 3–6 month GLP-1 phase can work as a powerful accelerator if users simultaneously:

• Learn portion control
  
  

• Build protein-first eating habits
  
  

• Preserve muscle mass
  
  

• Address digestion and nutrient gaps
  
  

• Create routines they can sustain after medication
  
  

Without this, GLP simply postpones the problem.

Why This Is Especially Critical for Indians

Indians have a unique metabolic profile:

• Higher visceral fat at lower BMIs
  
  

• Lower baseline protein intake
  
  

• Greater risk of muscle loss during rapid weight loss
  
  

• Higher susceptibility to deficiencies when appetite drops
  
  

GLP-1 suppresses appetite — but appetite suppression without guidance often leads to:

• Skipped meals
  
  

• Poor protein intake
  
  

• Digestive distress
  
  

• Fatigue and weakness
  
  

• Long-term metabolic slowdown
  
  

This is not a failure of GLP-1.
It’s a failure of support systems.

Pharma Will Own Weight Loss — But Not Behavior

For over 100 years, weight loss remained an unorganised market:

• Nutritionists managing a few clients
  
  

• Gyms selling memberships
  
  

• Apps selling subscriptions
  
  

• Supplements promising shortcuts
  
  

Despite billions in value, obesity kept rising.

GLP-1 changes that equation. Pharma now owns the most effective lever we’ve ever had for appetite control.

But appetite control alone is not health.

Behavior, nutrition, muscle preservation, and long-term adherence cannot be solved by a prescription alone.